Healthcare as a Pillar of Competitiveness

Mr. Immelt will share how improving healthcare is central to future competitiveness. He will discuss the role of innovation in breaking through the barriers of cost, quality and access and share his thoughts on sustaining healthcare and innovation in meaningful ways. His comments will be followed with a conversation with Maria Bartiromo.

The State of Cardiovascular Drug Development

Moderator: Roger Longman, Chief Executive Officer, Real Endpoints

Leaders of the major pharmaceutical companies review the systematic breakthroughs in cardiovascular pharmacology and discuss how careful planning - not serendipity - has helped achieve significant advancements in the current treatment.

The Grand Scientific Challenges in Cardiovascular Care

Cardiovascular Care's Most Pressing Challenges

Cleveland

Bruce Lytle, MD

Chair, Heart and Vascular Institute, Cleveland Clinic

Perspectives from the Top of Industry

Moderator: Maria Bartiromo, Anchor, CNBC

Leaders of some of the most influential organizations in healthcare provide their unique outlook on the current challenges and strengths of the healthcare industry, the climate for innovation, where we are, and where we are headed.

Peripheral Arterial Disease: New Innovations to Treat a Growing Cohort

Moderator: Michelle Cortez, Bloomberg

Peripheral Artrerial Disease is considered a largely unaddressed disease market mostly due to the special challenges of fighting cardiovascular disease in the periphery. Top leaders in the field discusses the prospect for new breakthroughs.

Partnering for Biomedical Innovation: Starting the Dialogue

Ian Read, Chief Executive Officer, Pfizer

Biomedical innovation has improved human life and created wealth in our society, but there are challenges to ongoing innovation in medicine. The talk will examine these challenges and create an opportunity to start a dialogue among healthcare providers across the industry to evaluate how, together, we can earn the respect of society, alter policies to support ongoing medical innovation and collaborate to create more efficient ways to treat patients.

Immelt: 'Our job is to make our ideas his ideas'

Immelt likes equations almost as much as I like graphs. For health care, it's "cost = usage x price(inflation)." Implication: To tackle cost, you either need to get usage down, by making people healthier or restricting access, or get prices down, either through price controls or innovation.

FDA Regulations Stifle Medical Device Innovation

The rate of medical innovation in the United States has fallen behind global competitors as manufacturers and investors struggle to work through inefficient regulatory processes, said medical industry and manufacturing leaders speaking at a Cleveland Clinic conference Oct. 3.

Cleveland Clinic's Medical Innovation Summit opens Monday

It's a gathering of technology, medicine and business that over the years has grown in international stature. Now in its ninth year, the assemblage will include machine matching wits with man and various arms of industry associations and competing businesses appearing -- in some cases, for the first time -- side by side.